Burfiralimab Antibody
Burfiralimab (hzVSF-v13) is an anti-vascular stromal fibroblast (VSF) IgG4 monoclonal antibody with demonstrated anti-HBV activity. It serves as a research tool for investigating rheumatoid arthritis and related autoimmune pathologies, with utility in both in vitro cellular assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
HzVSF-v13, HBV
Target
Interleukin, SARS-CoV, HBV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Infectious Disease & Virology
Concentration
9.82 mg/mL
Purity
90.00% (May vary between batches)
Molecular Weight
144.6 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV652919 1.0 µg DNA
CEBPD Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details 
